Global Foot and Mouth Disease (FMD) Vaccines Market Overview
According to Global Market Monitor, the global foot and mouth disease vaccine market will reach $196.25 million in 2024 with a CAGR of 6.78% from 2024 to 2029.Foot and mouth disease vaccines provide active acquired immunity to foot and mouth disease. This highly contagious viral disease primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep, and goats.
Market Drivers
The FMD vaccine market is driven by several factors, including growing consumer demand for animal protein, enhanced government initiatives to control and prevent FMD outbreaks, and increased public awareness of the benefits of vaccination. The growing demand for animal protein, especially in emerging economies, is driving the expansion of the foot and mouth disease vaccine market. As the global population and economy improve, so does the demand for meat, milk, and other animal products, resulting in increased animal productivity and thus increased demand for FMD vaccines.
In addition, governments around the world are taking substantial steps to contain and prevent foot-and-mouth disease outbreaks. Many countries have implemented national vaccination programs, including routine animal immunization and emergency vaccination in the event of an outbreak. These efforts have significantly increased the demand for FMD vaccination.
China and Mouth Disease (FMD) Vaccines Market Status
Foot-and-mouth disease vaccine is one of the three strong vaccines. Although the immune penetration rate is relatively high, a large proportion of vaccines are still recruited by the government, and the price is low and the quality is still far from that of market vaccines. According to the "National Guidelines on Compulsory Immunization against Animal Diseases (2022-2025)" issued in 2022, the government bidding for compulsory immunization vaccines will be gradually stopped before the end of 2025, and the market size is expected to increase.
Foot and Mouth Disease (FMD) Vaccines Market News
The 2023 National Science and Technology Award was recently announced in Beijing, and the "Creation and application of recombinant foot-and-mouth disease Type O and Type A bivalent inactivated vaccine for swine" presided over by Zheng Haixia, chief of the foot-and-mouth Disease and New Disease Epidemiology Team of Lanzhou Veterinary Research Institute of the Chinese Academy of Agricultural Sciences won the second prize of National Technological Invention.
This achievement is facing the international frontier scientific problems, breaking through the key new technology of the preparation of FMD vaccine seed virus, and filling the gap of swine type A vaccine. We invented high-yield vaccine seed virus production cell lines and high-efficiency media, innovative foot-and-mouth disease vaccine manufacturing technology system, the first large-scale intelligent manufacturing plant for foot-and-mouth disease vaccine, and improved the efficiency and quality of vaccine production. At the same time, it has also become the leading product of foot-and-mouth disease prevention and control in China, playing key technical support in solving the problem of foot-and-mouth disease prevention and control in China.
By Type |
Conventional Vaccines |
Emergency Vaccines |
|
The conventional vaccines segment contributes the largest market share. |
|
By Application |
Cattle |
Pigs |
|
Sheep and Goats |
|
The largest segment by application is the cattle. |
We provide more professional and intelligent market reports to complement your business decisions.